News
If we don’t invest in technologies like mRNA vaccines for pandemic influenza now, once a virus starts going human-to-human, ...
Moderna has interim data it says support advancing its avian influenza vaccine into a late-stage clinical trial, but the U.S. government has canceled the federal contract that would have financed ...
The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...
Moderna also said on Wednesday that it had received positive interim data from a mid-stage trial set up to test the safety and immunogenicity of its bird flu vaccine targeting the H5 avian ...
Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...
Phase 1/2 H5 avian flu vaccine study shows positive interim results. Company has been notified that HHS will terminate Moderna’s award for late-stage development of pre-pandemic influenza vaccines ...
Amidst an ongoing outbreak of a deadly bird flu virus in livestock, the US Department of Agriculture is doing more to prevent ...
Cambodia's health ministry yesterday reported two more human H5N1 avian flu cases, part of a spike in cases in June, with six ...
Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial. In a Phase 3 study, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results